All Immunology articles – Page 12
-
NewsWhat drives food allergies? New study pinpoints early-life factors that raise risk - including microbiome
A new study involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. Genetics alone cannot fully explain food allergy trends, pointing to interactions between genes, skin health, the microbiome, and environmental exposures.
-
NewsEthris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), have announced a strategic research collaboration to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
NewsConstruction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
A new article discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
-
NewsDiscovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
A new article publication discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
-
NewsNew study: Immune cells linked to Epstein-Barr virus may play a role in MS
Researchers have found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune response seen in MS.
-
NewsStudy reveals dual forces driving SARS-CoV-2 evolution: Immune pressure and viral fitness
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
-
NewsA rapid evolutionary process provides Sudanese Copts with resistance to malaria
An international study investigating the genomic diversity of the Sudanese population reveals that the Copts originating in Egypt –who settled in the country between the seventh and eleventh centuries– have acquired a genetic variant that protects them from contracting malaria.
-
NewsA mint idea becomes a game changer for medical devices
Researchers have developed a high‑performance coating made from peppermint essential oil that can be applied to the surfaces of many commonly used medical devices, offering a safer way to protect patients from infection and inflammation.
-
NewsYeast cells can be used for rapid testing of cancer immunotherapy
An international research team has developed a new yeast-based biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before. It can reduce development time for new types of cancer immunotherapy from months to days or weeks.
-
NewsBlood test may give insights into a person’s infection history
Which infections have you already come into contact with? In the future, a simple blood test may be all you need to answer that question. Researchers intend to investigate the sensors the immune system uses to identify pathogens.
-
NewsSugar molecules point to a new weapon against drug-resistant bacteria
Researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognise a sugar found only on bacterial cells – an advance that could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.
-
NewsGut microbe–derived butyrate activates immune cells to enhance vaccine efficacy
Researchers have uncovered a new mechanism showing how butyrate—a short-chain fatty acid produced by gut commensal bacteria—enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.
-
NewsResearchers urge focus on child obesity and gut health to reduce risk of diabetes
Researchers are calling for more study of obesity, gut bacteria and metabolic conditions that arise in childhood and adolescence, with an eye to curbing the global rise of type 2 diabetes.
-
NewsScientists demonstrate first-ever single-shot HIV vaccine neutralization success
Scientists have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates.
-
NewsLaunch of clinical trial of investigative nasal spray medicine to prevent illnesses from respiratory viruses
A new clinical trial will test a new experimental intranasal spray designed to boost immune defenses and reduce illness from respiratory viruses.
-
NewsStudy suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women
In a modeling study of women vaccinated against human papillomavirus (HPV), researchers found that cervical cancer screening could be done far less often than current recommendations without compromising health benefits.
-
NewsGut bacteria may tip the balance between feeding tumors and fueling immunity
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer.
-
NewsMetformin shown to prevent Long COVID across risk groups in multiple randomized trials
Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing Long COVID when taken during or shortly after acute infection with SARS-CoV-2.
-
NewsNasal vaccine combats bird flu infection in rodents
Researchers have developed an intranasal H5N1 vaccine that elicited strong immune responses when tested in hamsters and mice and prevented infections in exposed animals. The team also confirmed their vaccine remained effective regardless of prior flu exposure.